Abvc Biopharma (ABVC) Revenue (2010 - 2025)
Abvc Biopharma's Revenue was -$764,171 in Q4 2025, compared with $1,966 a year earlier.
Powered by 
Analysis
Abvc Biopharma (ABVC) Revenue (2010 - 2025) Analysis & Trends
For FY2025, Revenue at Abvc Biopharma came in at $31,779, down 93.8% from FY2024.
- Revenue shows a five-year compound annual growth rate of -42.0% (FY2020 to FY2025).
- In earlier years, Revenue was $509,589 in FY2024 (+234.3%), $152,430 in FY2023 (-84.3%), $969,783 in FY2022 (+172.6%) and $355,797 in FY2021 (-26.3%).
- The Q4 2025 figure marks the lowest quarterly Revenue in data going back to Q3 2010.
- The best year-over-year quarter for Revenue over five years was Q2 2022 (growth of 895.1%); the worst was Q4 2023 (a decline of 99.6%).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 25.31 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | 16.99 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 16.61 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | 14.41 Bn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | 15.38 Bn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 10.05 Bn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | 7.80 Bn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | 15.03 Bn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 3.33 Bn |
| 10 | Abvc Biopharma | 27.31 Mn | 29.30 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | -764,171.00 |
| Dec 31, 2024 | 1,966.00 |
| Sep 30, 2024 | 389,276.00 |
| Jun 30, 2024 | 117,142.00 |
| Mar 31, 2024 | 1,205.00 |
| Dec 31, 2023 | 2,165.00 |
| Sep 30, 2023 | 15,884.00 |
| Jun 30, 2023 | 6,109.00 |
| Mar 31, 2023 | 128,272.00 |
| Dec 31, 2022 | 588,994.00 |
| Sep 30, 2022 | 42,269.00 |
| Jun 30, 2022 | 312,860.00 |
| Mar 31, 2022 | 25,660.00 |
| Dec 31, 2021 | -37,793.00 |
| Sep 30, 2021 | 98,999.00 |
| Jun 30, 2021 | 31,441.00 |
| Mar 31, 2021 | 263,150.00 |
| Dec 31, 2020 | 62,193.00 |
| Sep 30, 2020 | 115,553.00 |
| Jun 30, 2020 | 226,513.00 |
API Access
Abvc Biopharma Revenue API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=revenue&ticker=ABVC&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "revenue", "ticker": "ABVC", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=revenue&ticker=ABVC&period=max&api_key=YOUR_API_KEY");
const data = await res.json();